Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · IEX Real-Time Price · USD
25.44
+2.18 (9.37%)
At close: Jul 1, 2024, 4:00 PM
26.01
+0.57 (2.24%)
Pre-market: Jul 2, 2024, 7:32 AM EDT
Rapport Therapeutics Statistics
Total Valuation
RAPP has a market cap or net worth of $899.98 million. The enterprise value is $708.61 million.
Market Cap | 899.98M |
Enterprise Value | 708.61M |
Important Dates
The next estimated earnings date is Saturday, August 10, 2024, before market open.
Earnings Date | Aug 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RAPP has 35.38 million shares outstanding.
Shares Outstanding | 35.38M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.10
Current Ratio | 20.10 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$884,621 |
Employee Count | 58 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 61.47 |
Average Volume (20 Days) | 376,204 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | -51.31M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$1.45 |
Balance Sheet
The company has $193.35 million in cash and $1.98 million in debt, giving a net cash position of $191.37 million or $5.41 per share.
Cash & Cash Equivalents | 193.35M |
Total Debt | 1.98M |
Net Cash | 191.37M |
Net Cash Per Share | $5.41 |
Equity (Book Value) | -39.63M |
Book Value Per Share | -1.12 |
Working Capital | 188.84M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RAPP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -5.70% |
FCF Yield | n/a |
Analyst Forecast
The average price target for RAPP is $35.00, which is 37.58% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $35.00 |
Price Target Difference | 37.58% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |